(Reuters Health) – Transgender adolescents and young adults on gender-affirming hormone therapy don’t appear to be at increased risk of thrombosis with short-term use, a
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
